Acute hepatitis associated with oral levofloxacin therapy in a hemodialysis patient

CMAJ. Canadian Medical Association Journal

Volumn 168, Issue 7, 2003, Pages 847-848

  Schwalm, Jon David ^a   Lee, Christine H ^a,b  

^a MCMASTER UNIVERSITY   (Canada)

^b ST JOSEPH S HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ALANINE AMINOTRANSFERASE; ALCOHOL; ALKALINE PHOSPHATASE; ASCORBIC ACID; ASPARTATE AMINOTRANSFERASE; CALCIUM CARBONATE; CAPTOPRIL; DIGOXIN; ERYTHROPOIETIN; FOLIC ACID; HERBACEOUS AGENT; HYDROMORPHONE; INSULIN; ISOPHANE INSULIN; ISOSORBIDE DINITRATE; LEVOFLOXACIN; LIVER ENZYME; METOPROLOL; NON PRESCRIPTION DRUG; OMEPRAZOLE; QUININE SULFATE; QUINOLINE DERIVED ANTIINFECTIVE AGENT; VITAMIN B GROUP;

ABOVE KNEE AMPUTATION; ACUTE HEPATITIS; AGED; AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; CASE REPORT; CELLULITIS; DRUG TOLERABILITY; GANGRENE; HEMODIALYSIS PATIENT; HUMAN; LIVER CELL DAMAGE; MALE; SKIN INFECTION; SOFT TISSUE INFECTION; URINARY TRACT INFECTION;

EID: 0037387817     PISSN: 08203946     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. Karim A, Ahmed S, Rosshoff LJ, Siddiqui RK, Steinberg HN. Possible levofloxacin-induced hepatocellular injury in a patient with chronic obstructive lung disease. Clin Infict Dis 2001;33:2088-90.
2. Norrby SR. Levofloxacin. Expert Opin Pharmacother 1999;1(1):109-19.
3. Fish DN, Chow AT. The clinical pharmacokinetics of levofloxacin. Clin Pharmacokinet 1997;32:109-19.
4. Kahn JB. Latest industry information on the safety profile of levofloxacin in the US. Chemotherapy 2001;47(Suppl 3):32-7.
5. Levofloxacin [package insert]. Raritan (NJ): Ortho Pharmaceutical Corp; 1996.
6. Wolfson JS, Hooper DC. Overview of fluoroquinolone safety. Am J Med 1991;91(Suppl 6A):153-61.
7. Bertino J, Douglas F. The safety profile of the fluoroquinolones. Clin Ther 2000;22(7):798-817.
8. Lipsky BA, Baker CA. Fluoroquinolone toxicity profiles: a review focusing on newer agents. Clin Infect Dis 1999;28:352-64.
9. Spahr L, Rubbia-Brandt L, Marinescu O, Armenian B, Hadengue A. Acute fatal hepatitis related to levofloxacin. J Hepatol 2001;35(2):308-9.
10. Gonzalez Carro, Huidobro ML, Zabala AP, Vicente EM. Fatal subfulminant hepatic failure with ofloxacin [letter]. Am J Gastroenterol 2000;95(6):1606.
11. Henann NE, Zambie MF. Gatifloxacin-associated acute hepatitis. Pharmacotherapy 2001;21(12):1579-82.
12. Contreras MA. Luna R, Mulero J, Andreu JL. Severe ciprofloxacin-induced acute hepatitis. Eur J Clin Microbiol Infect Dis 2001;20(6):434-5.